AMGEN CANADA INC. v. MYLAN PHARMACEUTICALS ULC. ET AL
Summary of T-2056-14
The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.
Federal Court Type: S. 18.1 Patented Medicines (Notice of Compliance) Regulations
Parties and Lawyers:| Party | Firm | Lawyer |
|---|---|---|
| AMGEM CANADA INC | Torys LLP | SHAUGHNESSY, ANDREW |
| MINISTER OF HEALTH (THE) | ||
| MYLAN PHARMACEUTICALS ULC | ||
| NPS PHARMACEUTICALS INC |
| Name | Number |
|---|---|
| 2202879 |
Patented Medicine: Cinacalcet (Medicinal ingredients are based on automated analysis and should not be relied upon.)
Decisions
| Name | Date | Paragraph |
| Amgen Canada Inc. v. Mylan Pharmaceuticals ULC. 2015 FC 1244 | Nov 3, 2015 | This is an application, pursuant to s 6 of the Patented Medicines (Notice of Compliance) Regulations, by Amgen against Mylan, the Minister of Health Minister and NPS Pharmaceuticals, Inc for an order prohibiting the Minister from issuing a Notice of Compliance to Mylan. The patent at issue is the 879 Patent, which claims a vast number of compounds. The sole claim at issue is Claim 5, which specifically claims the compound Cinacalcet and its pharmaceutically acceptable salts. Amgen conceded that Cinacalcet was disclosed in the prior art but claims that Claim 5 is a selection invention. The Court found that Amgen had failed to establish a substantial and unexpected advantage, either quantitative or qualitative, in respect of either the 879 Patent as a whole or with respect to Claim 5 in particular. The Court concluded that the 879 Patent was anticipated and obvious. The application was dismissed with costs. |
Docket Summary (Google Translate to English)
() 2016-07-29 - OttawaConfirmation by fax printout of receipt by the parties of the Order/ Direction of Mr. Justice Phelan dated 29-JUL-2016 placed on file on 29-JUL-2016
Order/Direction dated 29-JUL-2016 rendered by The Honourable Mr. Justice Phelan Matter considered without personal appearance The Court's decision is with regard to Motion in writing Doc. No. 25 Result: the Respondent Mylan Pharmaceuticals ULC., shall be entitled to costs fixed at the mid-point of Column IV of the Tariff and costs of a second counsel including travel fees. There are no costs on this motion Filed on 29-JUL-2016 copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1307 page(s) 396 - 397 Interlocutory Decision
Letter from Respondent dated 25-JUL-2016 inquiring about the status of the motion for directions on costs (scanned to the Court) received on 25-JUL-2016
Certified French language Translation of Reasons for Judgment rendered on 03-NOV-2015 by The Honourable Mr. Justice Phelan filed on 15-JUN-2016 pursuant to s. 20 of the Official Languages Act.
Memorandum to file from D.Parent - Ottawa dated 26-JAN-2016 DARS CDs per request ID:79 sent to Toronto for P/U by client. placed on file.
Oral directions received from the presiding judge dated 14-JAN-2016 directing that the request for copies of the Audio Recording of matter heard Sept 8-10 2015 is granted placed on file on 14-JAN-2016
Request for Copy of Audio Recording on behalf of Torys LLP received on 13-JAN-2016
Communication to the Court from the Registry dated 15-DEC-2015 re: Motion doc.25 sent to presiding Judge for disposition.
Covering letter from the Respondent Mylan Pharmaceuticals dated 11-DEC-2015 concerning Doc. Nos. 36 37 placed on file on 11-DEC-2015
Solicitor's certificate of service on behalf of Faylene Lunn confirming service of Written representations in reply doc.36 upon Applicant by personal service on 11-DEC-2015 confirming service Written representations in reply doc.36 upon the Respondent the Minister of Health by email on 11-DEC-2015 confirming service Written representations doc.36 upon the Respondent/Patentee by personal service on 11-DEC-2015 filed on 11-DEC-2015
Written representations in reply on behalf of Respondent Mylan Pharmaceuticals ULC in response to the opposing submissions doc. No. 33 to the Motion in writing Filed on 11-DEC-2015
Solicitor's certificate of service on behalf of Alexandra Peterson confirming service of Doc 34 and Book of Authorities upon Respondents by same day courier on 07-DEC-2015 filed on 07-DEC-2015
Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 07-DEC-2015
Motion Record in response to Motion Doc. No. 25 containing the following original document(s): 32 33 Number of copies received: 3 on behalf of Applicant filed on 07-DEC-2015
Written Representations contained within a Motion Record on behalf of Applicant concerning Motion Doc. No. 25 filed on 07-DEC-2015
Affidavit of Diane Zimmerman sworn on 07-DEC-2015 contained within a Motion Record on behalf of Applicant with consent to extend the time for filing in opposition to Motion Doc. No. 25 with Exhibits a-h filed on 07-DEC-2015
Solicitor's certificate of service on behalf of Alexandra Peterson confirming service of doc 30 upon all parties by telecopier on 27-NOV-2015 filed on 27-NOV-2015
Consent on behalf of all parties to an extension of 5 days pursuant to R.7 for the applicants to serve and file its responding motion record and book of authorities in response to Mylan's motion in writing for directions as to costs filed on 27-NOV-2015
Letter from Applicant dated 27-NOV-2015 "...executed consent for an extension of 5 days for the applicant to serve and file its responding motion record and book of authorities in response to Mylan's motion in writing for directions as to costs." received on 27-NOV-2015
Covering letter from Respondent, Mylan Pharmaceuticals ULC dated 18-NOV-2015 concerning Doc. Nos. 28 29 placed on file on 18-NOV-2015
Solicitor's certificate of service on behalf of Faylene Lunn confirming service of Respondent's Motion Record and Book of Authorities (for Direction as to costs) upon Applicant, Respondent NPS Pharmaceuticals Inc. by hand on 18-NOV-2015 confirming service same upon Respondent, Minister of Health by electronic mail on 18-NOV-2015 filed on 18-NOV-2015
Book of Authorities consisting of 2 volume(s) on behalf of Respondent, Mylan Pharmaceuticals ULC (For motion Doc 25) received on 18-NOV-2015
Motion Record containing the following original document(s): 25 26 27 Number of copies received: 3 on behalf of Respondent, Mylan Pharmaceuticals ULC filed on 18-NOV-2015
Written Representations contained within a Motion Record on behalf of Respondent concerning Motion Doc. No. 25 filed on 18-NOV-2015
Affidavit of Nicole McDonald sworn on 18-NOV-2015 contained within a Motion Record on behalf of Respondent in support of Motion Doc. No. 25 with Exhibits A-J filed on 18-NOV-2015
Notice of Motion contained within a Motion Record on behalf of Respondent, Mylan Pharmaceuticals ULC in writing to be placed before the Court in Ottawa for a Direction of the Court as to costs filed on 18-NOV-2015
Acknowledgment of Receipt received from All parties with respect to Reasons for Judgment (doc. no. 24) placed on file on 03-NOV-2015
Reasons for Judgment dated 03-NOV-2015 rendered by The Honourable Mr. Justice Phelan The Court's decision is with regard to Judicial Review (s.18) Filed on 03-NOV-2015 Copies sent to All parties
Acknowledgment of Receipt received from all parties (by fax) with respect to doc 23 placed on file on 19-OCT-2015
Judgment dated 19-OCT-2015 rendered by The Honourable Mr. Justice Phelan Matter considered with personal appearance The Court's decision is with regard to Judicial Review (s.18) Result: dismissed THIS COURT'S JUDGEMENT is that the application to prohibit the Minister of Health from issuing a Notice of Compliance to Mylan Pharmaceuticals ULC., until the 879 Patent expires, is hereby dismissed with costs. Filed on 19-OCT-2015 copies sent to parties entered in J. & O. Book, volume 1280 page(s) 306 - 307 Final Decision
Toronto 08-SEP-2015 BEFORE The Honourable Mr. Justice Phelan Language: E Before the Court: Judicial Review Result of Hearing: Matter reserved held in Court Senior Usher: Doug Duff Duration per day: 08-SEP-2015 from 09:30 to 16:30 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Abigail Grimes 09-SEP-2015 from 09:30 to 16:40 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Abigail Grimes 10-SEP-2015 from 09:30 to 15:40 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Abigail Grimes Total Duration: 3d Appearances: Mr. Andrew Shaughnessy / Ms. Alexandra Peterson / Mr. Andrew Bernstein 416-865-0040 representing Amgen Canada Inc., Applicant Mr. J. Bradley White / Mr. Vincent M. de Grandpre / Mr. Geoffrey Langen 613-235-7234 representing Mylan Pharmaceuticals ULC, Respondent Comments: DARS Z005120 Minutes of Hearing entered in Vol. 936 page(s) 117 - 134 Abstract of Hearing placed on file
Compendium of the Respondent Mylan Pharmaceuticals ULC - Anticipation, Obviousness and Double Patenting received at hearing on 10-SEP-2015
Outline of the Respondent Mylan Pharmaceuticals ULC - Anticipation, Obviousness and Double Patenting (no local copy) received at hearing on 10-SEP-2015
Compendium of the Respondent Mylan Pharmaceuticals ULC - The 879 Patent is not a Selection Patent (3 volumes) *no local copy received at hearing on 09-SEP-2015
Compendium of the Respondent Mylan Pharmaceuticals ULC - Key Documents (no local copy) received at hearing on 09-SEP-2015
Outline of Arguments of the Respondent Mylan Pharmaceuticals ULC - The 879 Patent is not a Selection Patent (no local copy) received at hearing on 09-SEP-2015
Supplementary Book of Authorites (no local copy) consisting of 1 volume(s) on behalf of Respondent received on 08-SEP-2015
Supplementary Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 08-SEP-2015
Compendium of the Applicant (2 volumes) received at hearing on 08-SEP-2015
Amgen's Outline of Argument received at hearing on 08-SEP-2015
Letter from Applicant dated 17-AUG-2015 requesting a breakout room for use during the hearing scheduled 08-SEP-2015 received on 17-AUG-2015
Letter from Respondent dated 13-AUG-2015 requesting a breakout room for use during the hearing scheduled 08-SEP-2015 received on 14-AUG-2015
Copy of E-mail received from Respondent's counsel, Mylan Pharmaceuticals which was sent to Respondent, Minister of Health with proof that the Minister consents to electronic service of Book of Authorities of the Respondent Mylan.. received on 27-JUL-2015
Covering letter from Respondent, Mylan Pharmaceuticals ULC dated 24-JUL-2015 concerning Authorities and Record placed on file on 24-JUL-2015
Solicitor's certificate of service on behalf of Vincent M. de Grandpré confirming service of document id 39, 40 upon Applicant by personal service on 24-JUL-2015 confirming service document id 39, 40 upon Respondent, Minister of Health by (id 39 by electronic mail) (id 40 by overnight courier) with consent on 24-JUL-2015 confirming service document 39, 40 upon Respondent/Patentee by personal service on 24-JUL-2015 filed on 24-JUL-2015
Book of Authorities consisting of 3 volume(s) on behalf of Respondent (Mylan Pharmaceuticals ULC) received on 24-JUL-2015
Respondent's Record (Mylan Pharmaceuticals ULC) Number of copies received/prepared: 3 on behalf of Respondent filed on 24-JUL-2015
Covering letter from Applicant dated 09-JUL-2015 concerning Doc. Nos. 18 19 20 placed on file on 09-JUL-2015
Solicitor's certificate of service on behalf of ALEXANDRA PETERSON confirming service of DOC 18, BOOK OF AUTH upon RESPONDENTS (MYLAN PHARMA, NPS PHARMA AND AGC) by SAME DAY COURIER on 24-JUN-2015 filed on 09-JUL-2015
Sealed envelope pursuant to Protective Order dated 19-DEC-2014 on behalf of Applicant purporting to contain Confidential Voume 9 of Applicant's Record (doc 18) Filed on 09-JUL-2015
Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 09-JUL-2015
Application Record (vol.1-14) Number of copies received/prepared: 3 on behalf of Applicant filed on 09-JUL-2015
Oral directions received from the Court: Martha Milczynski, Prothonotary dated 03-JUL-2015 directing that the Applicant is granted leave to file a public and confidential version of volume 9 of their Applicant's Record (NOTE: Parties advised via electronic mail) placed on file on 03-JUL-2015
Letter from Applicant dated 02-JUL-2015 requesting a direction to allow the filing of a public and confidential version of volume 9 of their Applicant's record (cc'd to all parties) received on 02-JUL-2015
Letter from Applicant dated 22-JUN-2015 advising that they will not be bringing a R.151 motion for a confidentiality order (cc'd to all parties) received on 22-JUN-2015
Letter from Respondent - NPS Pharmaceuticals Inc. dated 22-JUN-2015 advising that they will not be bringing a R.151 motion for a confidentiality order (cc'd to all parties) received on 22-JUN-2015
Toronto 09-JUN-2015 BEFORE Martha Milczynski, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: If required, the Court will hear Amgen's R.151 motion on Monday, June 29, 2015 at 9;30 a.m. (See "Comments" section for filing deadlines) held by way of Conference Call in chambers Duration per day: 09-JUN-2015 from 10:00 to 10:25 Courtroom : Judge's Chambers - Toronto Court Registrar: Natashia Bennett-Nelson Total Duration: 25min Appearances: Alexandra Peterson (416) 865-8114 representing Applicant Vincent de Grandpre / Brad Jenkins (416) 862-6570 representing Respondent - Mylan Tony Prenol (416) 863-4292 representing Respondent - NPS Pharmaceuticals Comments: Parties to advise the Court by June 22, 2015 if the motion will proceed on the 29th. Applicant to serve their record on the Respondents by June 24, 2015 and file the same by July 9, 2015. All motion material to be served and filed by June 25, 2015. Minutes of Hearing entered in Vol. 931 page(s) 406 - 408 Abstract of Hearing placed on file
Oral directions received from the Court: Martha Milczynski, Prothonotary dated 08-JUN-2015 directing that a case management teleconference will be held on June 9, 2015 at 10:00 a.m. (NOTE: Parties advised by electronic mail) placed on file on 08-JUN-2015
Letter from Applicant dated 08-JUN-2015 requesting a direction from the Court permitting them to file a confidential version of the application record under seal pending disposition of a (yet to be filed) R.151 motion (cc'd to all parties) received on 08-JUN-2015
Covering letter from Respondent Mylan Pharmaceuticals dated 06-MAR-2015 concerning Doc. No. 17 placed on file on 06-MAR-2015
Solicitor's certificate of service on behalf of Brad Jenkins confirming service of Confidential Affidavits of Dr.Philip A. Marsden, Dr.William D. Lubell and Dr Peter A. Friedman upon all parties by courier and/or email (on agreement) on 06-MAR-2015 filed on 06-MAR-2015
Acknowledgment of Receipt received from all parties (via fax confirmation) with respect to doc. 16 placed on file on 19-DEC-2014
PROTECTIVE ORDER dated 19-DEC-2014 rendered by Martha Milczynski, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 08-DEC-2014 Result: granted Filed on 19-DEC-2014 copies sent to parties entered in J. & O. Book, volume 1253 page(s) 289 - 303 Interlocutory Decision
Solicitor's certificate of service on behalf of Alexandra Peterson confirming service of Applicant's R.306 Evidence upon all parties by Courier on 19-DEC-2014 filed on 19-DEC-2014
Communication to the Court from the Registry dated 08-DEC-2014 re: A's letter with draft protective order and consent
Letter from Applicant dated 08-DEC-2014 with attached consent and draft protective order (cc'd to all parties) received on 08-DEC-2014
****** CANCELLED ****** Communication to the Court from the Registry dated 05-DEC-2014 re: Sent to JA's office for a hearing date to be set down.
Toronto 27-NOV-2014 BEFORE Martha Milczynski, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Parties confirm availability for a three day hearing commencing on September 8, 2015 held by way of Conference Call in chambers Duration per day: 27-NOV-2014 from 09:30 to 09:45 Courtroom : Judge's Chambers - Toronto Court Registrar: Natashia Bennett-Nelson Total Duration: 15min Appearances: Mr. Andrew Bernstein / Ms. Alexandra Peterson (416) 865-7678 representing Applicant Mr. Vincent de Granpre / Mr. Brad Jenkins (416) 862-6570 representing Respondent Mr. Anthony Prenol (403) 262-1234 representing Patentee Comments: Timetable set - see Order to be issued by this Court on 27-NOV-2014 Minutes of Hearing entered in Vol. 918 page(s) 183 - 184 Abstract of Hearing placed on file
Solicitor's certificate of service on behalf of Alexandra Peterson confirming service of Doc. # 13 - Requisition for Hearing upon Respondents by telecopier on 27-NOV-2014 filed on 27-NOV-2014
Requisition for hearing - Application from Applicant filed on 27-NOV-2014 Tariff Application or appeal - $50.00
Order dated 27-NOV-2014 rendered by Martha Milczynski, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: 1. The hearing of this application shall be in English at the Federal Court in Toronto on September 8, 2015 for 3 days. 2. The following timetable shall apply: a. December 19, 2014 - Amgen shall service its evidence. b. March 6, 2015 - Mylan shall serve its evidence. c. March 13, 2015 - The applicant shall req. a cmc to discuss the status of this proceeding. d. May 22, 2015 - Cross-examinations shall be completed. e. June 24, 2015 - Amgen shall serve and file its Application Record f. July 24, 2015 - Mylan shall serve and file its application record. g. Amgen shall forthwith serve and file the requistion for hearing. Filed on 27-NOV-2014 entered in J. & O. Book, volume 1250 page(s) 157 - 158 Interlocutory Decision
Toronto 24-NOV-2014 BEFORE Martha Milczynski, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Applicant to file Requisition for Hearing seeking a three day hearing date in August or September 2015 held by way of Conference Call in chambers Duration per day: 24-NOV-2014 from 09:35 to 09:45 Courtroom : Judge's Chambers - Toronto Court Registrar: Natashia Bennett-Nelson Total Duration: 10min Appearances: Mr. Andrew Bernstein / Ms. Alexandra Peterson (416) 865-7678 / (416) 865-8114 representing Applicant Mr. Vincent de Grandpré / Mr. Brad Jenkins (416) 862-6570 / (613) 787-1026 representing Respondent Minutes of Hearing entered in Vol. 917 page(s) 466 - 467 Abstract of Hearing placed on file
Toronto 20-OCT-2014 BEFORE Martha Milczynski, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: December 15, 2014 - The applicant to file a Requisition for Hearing December 19, 2014 - Amgen to serve its affidavits. March 6, 2015 - Mylan to serve its affidavits. CMC scheduled for November 24 @ 9:30 to discuss possible NOC appliation on '487 patent and to address remainder of the schedule. held in chambers Duration per day: 22-OCT-2014 from 11:30 to 11:50 Courtroom : Judge's Chambers - Toronto Court Registrar: Christopher Garito Total Duration: 20min Appearances: Mr. Shaughnessy 416-865-8171 representing Applicant Mr. White 416-862-6570 representing Respondent Minutes of Hearing entered in Vol. 915 page(s) 142 - 143 Abstract of Hearing placed on file
Solicitor's certificate of service on behalf of Anthony Prenol confirming service of doc 10 upon all parties by telecopier on 20-OCT-2014 filed on 20-OCT-2014
Notice of appearance on behalf of Repsondent: NPS Pharmaceuticals filed on 20-OCT-2014
Affidavit of service of Glen Burroughs sworn on 16-OCT-2014 on behalf of Plaintiff confirming service of doc 1 upon the respondent, NPS Pharmaceuticals, INC by personal service on 10-OCT-2014 filed on 17-OCT-2014
Affidavit of service of Ray Patykewich sworn on 07-OCT-2014 on behalf of Applicant confirming service of doc 1 upon Respondent by personal service on 06-OCT-2014 filed on 14-OCT-2014
Solicitor's certificate of service on behalf of the Respondent, Mylan Pharmaceuticals ULC confirming service of Notice of Appearance upon all parties by telecopier on 14-OCT-2014 filed on 14-OCT-2014
Notice of appearance on behalf of Respondent, Mylan Pharmaceuticals ULC filed on 14-OCT-2014
Covering letter from Respondent, Mylan Pharmaceuticals ULC dated 14-OCT-2014 concerning Noitce of Appearance placed on file on 14-OCT-2014
Order dated 10-OCT-2014 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Special Case Result: "IT IS ORDERED pursuant to Rule 383 that Prothonotary Marthat Milczynski is assigned as Case Management Judge in this matter." Filed on 10-OCT-2014 entered in J. & O. Book, volume 1245 page(s) 168 - 168 Interlocutory Decision
Affidavit of service of James Adeney sworn on 09-OCT-2014 on behalf of Respondent - Minister of Health confirming service of Doc. # 3 upon Applicant Respondent, Mylan Pharmacheuticals ULC and Respondent NPS Pharmaceuticals by Fax to Applicant and Mylan and courier to NPS. on 09-OCT-2014 with Exhibits "A-B" filed on 09-OCT-2014
Notice of appearance on behalf of Respondent - The Minister of Health filed on 09-OCT-2014
Service copy of Doc. No. 1 with proof of service upon Respondent on 06-OCT-2014 filed on 06-OCT-2014
Notice of application and 2 copies with regard to Intellectual Property filed on 03-OCT-2014 Certified copy(ies)/copy(ies) transmitted to Director of the Regional Office of the Department of Justice Tariff fee of $50.00 received: yes
The official version of the court proceeding information is available from the court websites directly: